We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information
Learn more about prostate cancer, answer a few brief questions to find out if you may qualify for a study, review a list of clinical studies that are now enrolling, and find other resources for support as you consider your next steps with prostate cancer.
You may qualify for a clinical trial.
divider
Below you will find a list of clinical studies that are sponsored by Bristol Myers Squibb (BMS). Click the links to get more information about each study. From the top of any trial page, click the purple “Check Your Eligibility” button to answer a few questions and find out if you qualify for a clinical study. If you are not a match for a study sponsored by BMS and you are a match for a study sponsored by another company, you will be shown those studies to consider.
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
A Study to Assess DF6002 (BMS-986415) Alone and in Combination With Nivolumab in Participants With Locally Advanced or Metastatic Solid Tumors
A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer
divider
Bristol Myers Squibb (BMS) is not affiliated with and does not endorse any of the listed organizations. The information and links provided by BMS are meant for informational purposes only and are not meant to replace a physician’s medical advice or imply endorsement. This is not a complete list of resources for this condition. There may be others that you may wish to explore.
divider
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information